225 related articles for article (PubMed ID: 31625482)
1. Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas.
Bertagna F; Albano D; Cerudelli E; Gazzilli M; Giubbini R; Treglia G
Curr Radiopharm; 2020; 13(2):94-98. PubMed ID: 31625482
[TBL] [Abstract][Full Text] [Related]
2.
Albano D; Tomasini D; Bonù M; Giubbini R; Bertagna F
Ann Nucl Med; 2020 Feb; 34(2):81-86. PubMed ID: 31773466
[No Abstract] [Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Radiolabelled PSMA PET/CT in breast cancer. A systematic review.
Bertagna F; Albano D; Cerudelli E; Gazzilli M; Tomasini D; Bonù M; Giubbini R; Treglia G
Nucl Med Rev Cent East Eur; 2020; 23(1):32-35. PubMed ID: 32779172
[TBL] [Abstract][Full Text] [Related]
5. Utility of 68Ga-PSMA-11 PET/CT in Imaging of Glioma-A Pilot Study.
Sasikumar A; Kashyap R; Joy A; Charan Patro K; Bhattacharya P; Reddy Pilaka VK; Oommen KE; Pillai MRA
Clin Nucl Med; 2018 Sep; 43(9):e304-e309. PubMed ID: 29939953
[TBL] [Abstract][Full Text] [Related]
6. Differential Uptake of 68Ga-PSMA-HBED-CC (PSMA-11) in Low-Grade Versus High-Grade Gliomas in Treatment-Naive Patients.
Verma P; Malhotra G; Goel A; Rakshit S; Chandak A; Chedda R; Banerjee S; Asopa RV
Clin Nucl Med; 2019 May; 44(5):e318-e322. PubMed ID: 30829867
[TBL] [Abstract][Full Text] [Related]
7. Prostate Cancer: Prostate-specific Membrane Antigen Positron-emission Tomography/Computed Tomography or Positron-emission Tomography/Magnetic Resonance Imaging for Staging.
Ferraro DA; Burger IA
Top Magn Reson Imaging; 2020 Feb; 29(1):59-66. PubMed ID: 32015295
[TBL] [Abstract][Full Text] [Related]
8. The Role of Radiolabeled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for the Evaluation of Renal Cancer.
Evangelista L; Basso U; Maruzzo M; Novara G
Eur Urol Focus; 2020 Jan; 6(1):146-150. PubMed ID: 30120074
[TBL] [Abstract][Full Text] [Related]
9.
Dyrberg E; Hendel HW; Huynh THV; Klausen TW; Løgager VB; Madsen C; Pedersen EM; Pedersen M; Thomsen HS
Eur Radiol; 2019 Mar; 29(3):1221-1230. PubMed ID: 30132104
[TBL] [Abstract][Full Text] [Related]
10.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
11. Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with
Matsuda M; Ishikawa E; Yamamoto T; Hatano K; Joraku A; Iizumi Y; Masuda Y; Nishiyama H; Matsumura A
J Neurooncol; 2018 Jul; 138(3):581-589. PubMed ID: 29524126
[TBL] [Abstract][Full Text] [Related]
12. PET/CT in comparison with PET/MRI as an imaging modality in the management of Gliomas: A systematic review and meta analysis.
Al-Lami BS; Al-Lami BS; Al-Lami YS
J Med Imaging Radiat Sci; 2024 Jun; 55(2):330-338. PubMed ID: 38490940
[TBL] [Abstract][Full Text] [Related]
13. PET/MRI in prostate cancer: a systematic review and meta-analysis.
Evangelista L; Zattoni F; Cassarino G; Artioli P; Cecchin D; Dal Moro F; Zucchetta P
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):859-873. PubMed ID: 32901351
[TBL] [Abstract][Full Text] [Related]
14. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
[TBL] [Abstract][Full Text] [Related]
15. PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis.
Xiong M; Chen Z; Zhou C; Yang X; Hu W; Jiang Y; Zheng R; Fan W; Mou Y; Lin X
Recent Pat Anticancer Drug Discov; 2024; 19(3):383-395. PubMed ID: 38214322
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous
Eiber M; Weirich G; Holzapfel K; Souvatzoglou M; Haller B; Rauscher I; Beer AJ; Wester HJ; Gschwend J; Schwaiger M; Maurer T
Eur Urol; 2016 Nov; 70(5):829-836. PubMed ID: 26795686
[TBL] [Abstract][Full Text] [Related]
17. Integrated
Lütje S; Cohnen J; Gomez B; Grüneisen J; Sawicki L; Rübben H; Bockisch A; Umutlu L; Pöppel TD; Wetter A
Nuklearmedizin; 2017 Jun; 56(3):73-81. PubMed ID: 28401244
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and grading accuracy of
Xiao J; Jin Y; Nie J; Chen F; Ma X
BMC Cancer; 2019 Aug; 19(1):767. PubMed ID: 31382920
[TBL] [Abstract][Full Text] [Related]
19. Early
Domachevsky L; Bernstine H; Goldberg N; Nidam M; Stern D; Sosna J; Groshar D
Clin Radiol; 2017 Nov; 72(11):944-950. PubMed ID: 28716214
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis.
Muoio B; Albano D; Dondi F; Bertagna F; Garibotto V; Kunikowska J; Piccardo A; Annunziata S; Espeli V; Migliorini D; Treglia G
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
